Scientists Create Blood Vessels, Capillaries for Lab-Grown Tissues
|
By LabMedica International staff writers Posted on 07 Feb 2011 |
Researchers have overcome one of the major hurdles on the path to growing transplantable tissue in the lab: they have found a way to grow the blood vessels and capillaries needed to keep tissues alive.
The new research, conducted by investigators from Rice University (Houston, TX, USA) and Baylor College of Medicine (BCM; Houston, TX, USA), is available online, and it was published in the January 2011 issue of the journal Acta Biomaterialia. "The inability to grow blood-vessel network --or vasculature--in lab-grown tissues is the leading problem in regenerative medicine today,” said lead coauthor Dr. Jennifer West, department chair, and professor of bioengineering at Rice. "If you don't have blood supply, you cannot make a tissue structure that is thicker than a couple hundred microns.”
As its base material, a team of researchers led by Dr. West and BCM molecular physiologist Dr. Mary Dickinson chose polyethylene glycol (PEG), a nontoxic plastic that is widely used in medical devices and food. Building on 10 years of research in Dr. West's lab, the scientists modified the PEG to mimic the body's extracellular matrix--the network of proteins and polysaccharides that comprise a considerable portion of most tissues.
Drs. West, Dickinson, Rice graduate student Jennifer Saik, Rice, undergraduate Emily Watkins, and Rice-BCM graduate student Daniel Gould combined the modified PEG with two kinds of cells--both of which are needed for blood-vessel formation. Using light that locks the PEG polymer strands into a solid gel, they created soft hydrogels that contained living cells and growth factors. After that, they filmed the hydrogels for 72 hours. By tagging each type of cell with a different colored fluorescent marker, the scientists were able to see as the cells gradually formed capillaries throughout the soft, plastic gel.
To assess these new vascular networks, the researchers implanted the hydrogels into the corneas of mice, where no natural vasculature exists. After injecting a dye into the mice's bloodstream, the researchers confirmed normal blood flow in the newly grown capillaries.
Another major development, conducted by Dr. West and graduate student Joseph Hoffmann, in November 2010, involved the generation of a new technique called two-photon lithography, an ultrasensitive method of using light to create intricate three-dimensional (3D) patterns within the soft PEG hydrogels. West said the patterning technique allows the engineers to exert a fine level of control over where cells move and grow. In follow-up research, also in collaboration with the Dickinson lab at BCM, Dr. West and her colleagues plan to use the technique to grow blood vessels in predetermined patterns.
Related Links:
Rice University
Baylor College of Medicine
The new research, conducted by investigators from Rice University (Houston, TX, USA) and Baylor College of Medicine (BCM; Houston, TX, USA), is available online, and it was published in the January 2011 issue of the journal Acta Biomaterialia. "The inability to grow blood-vessel network --or vasculature--in lab-grown tissues is the leading problem in regenerative medicine today,” said lead coauthor Dr. Jennifer West, department chair, and professor of bioengineering at Rice. "If you don't have blood supply, you cannot make a tissue structure that is thicker than a couple hundred microns.”
As its base material, a team of researchers led by Dr. West and BCM molecular physiologist Dr. Mary Dickinson chose polyethylene glycol (PEG), a nontoxic plastic that is widely used in medical devices and food. Building on 10 years of research in Dr. West's lab, the scientists modified the PEG to mimic the body's extracellular matrix--the network of proteins and polysaccharides that comprise a considerable portion of most tissues.
Drs. West, Dickinson, Rice graduate student Jennifer Saik, Rice, undergraduate Emily Watkins, and Rice-BCM graduate student Daniel Gould combined the modified PEG with two kinds of cells--both of which are needed for blood-vessel formation. Using light that locks the PEG polymer strands into a solid gel, they created soft hydrogels that contained living cells and growth factors. After that, they filmed the hydrogels for 72 hours. By tagging each type of cell with a different colored fluorescent marker, the scientists were able to see as the cells gradually formed capillaries throughout the soft, plastic gel.
To assess these new vascular networks, the researchers implanted the hydrogels into the corneas of mice, where no natural vasculature exists. After injecting a dye into the mice's bloodstream, the researchers confirmed normal blood flow in the newly grown capillaries.
Another major development, conducted by Dr. West and graduate student Joseph Hoffmann, in November 2010, involved the generation of a new technique called two-photon lithography, an ultrasensitive method of using light to create intricate three-dimensional (3D) patterns within the soft PEG hydrogels. West said the patterning technique allows the engineers to exert a fine level of control over where cells move and grow. In follow-up research, also in collaboration with the Dickinson lab at BCM, Dr. West and her colleagues plan to use the technique to grow blood vessels in predetermined patterns.
Related Links:
Rice University
Baylor College of Medicine
Latest BioResearch News
- Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
- Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
- Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
- Genetic Cause Identified for Severe Infant Epilepsy
- Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors
- Researchers Identify Survival Pathway Undermining Targeted Cancer Drugs
- Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
Channels
Clinical Chemistry
view channel
Blood Metabolite Test Detects Early Cognitive Decline
Timely identification of individuals at risk of dementia remains difficult because symptoms commonly appear only after significant neurodegeneration. Accessible screening tools that flag subtle cognitive... Read more
AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
Diagnosing the cause of age-related cognitive symptoms remains challenging because clinical presentations of neurodegenerative diseases often overlap, and multiple pathologies can co-occur... Read moreMolecular Diagnostics
view channel
ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery
Selecting surgery versus non-surgical management in early-stage breast cancer can be challenging for older patients, who often balance disease control with comorbidities and quality-of-life considerations.... Read more
WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity
Early detection of cancer remains difficult across many tumor types, and current single‑cancer screening modalities leave significant gaps. Blood‑based, multi‑cancer assays aim to detect tumor signals... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read moreMicrobiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read morePathology
view channel
AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer is typically guided by recurrence risk and population-level averages rather than patient-specific benefit. However, existing clinicopathologic... Read more
AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer remains a difficult decision because only a subset benefits and many undergo toxicity without gain. Genomic assays can help but are costly,... Read moreTechnology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channel
Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation
Takara Bio USA, Inc. (San Jose, CA, USA), a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company (Reno, NV, USA) announced a development and co-marketing agreement to deliver integrated, automated... Read more







